DNMT3A and chronic myelogenous leukemia, BCR-ABL1 positive: In CML, miR-217 sensitizes dasatinib-resistant cells through binding to several targets, including DNMT3A (DNA (cytosine-5)-methyltransferase 3A) and AGR2 (anterior gradient protein 2 homolog).